Parkwood LLC’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,696
| Closed | -$1.87M | – | 84 |
|
|
2024
Q2 | $1.87M | Buy |
13,696
+1,449
| +12% | +$198K | 0.23% | 69 |
|
|
2024
Q1 | $1.85M | Sell |
12,247
-3,849
| -24% | -$582K | 0.17% | 103 |
|
|
2023
Q4 | $2.03M | Sell |
16,096
-2,001
| -11% | -$252K | 0.24% | 63 |
|
|
2023
Q3 | $1.7M | Sell |
18,097
-515
| -3% | -$48.2K | 0.18% | 64 |
|
|
2023
Q2 | $1.66M | Sell |
18,612
-66
| -0.4% | -$5.89K | 0.3% | 64 |
|
|
2023
Q1 | $2M | Buy |
18,678
+1,125
| +6% | +$121K | 0.28% | 69 |
|
|
2022
Q4 | $2.14M | Sell |
17,553
-2,876
| -14% | -$351K | 0.33% | 63 |
|
|
2022
Q3 | $2.11M | Buy |
20,429
+2,824
| +16% | +$292K | 0.32% | 67 |
|
|
2022
Q2 | $1.64M | Sell |
17,605
-1,215
| -6% | -$113K | 0.29% | 75 |
|
|
2022
Q1 | $2.21M | Sell |
18,820
-1,972
| -9% | -$231K | 0.36% | 64 |
|
|
2021
Q4 | $2.8M | Sell |
20,792
-3,380
| -14% | -$455K | 0.48% | 60 |
|
|
2021
Q3 | $3.85M | Buy |
24,172
+5,992
| +33% | +$955K | 0.47% | 59 |
|
|
2021
Q2 | $2.39M | Sell |
18,180
-3,030
| -14% | -$399K | 0.28% | 66 |
|
|
2021
Q1 | $2.73M | Sell |
21,210
-4,104
| -16% | -$529K | 0.48% | 56 |
|
|
2020
Q4 | $4.22M | Sell |
25,314
-32,928
| -57% | -$5.49M | 0.51% | 54 |
|
|
2020
Q3 | $5.84M | Buy |
58,242
+25,081
| +76% | +$2.51M | 0.9% | 34 |
|
|
2020
Q2 | $4.91M | Buy |
+33,161
| New | +$4.91M | 0.88% | 35 |
|